Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy.
Ruseva MM, Peng T, Lasaro MA, Bouchard K, Liu-Chen S, Sun F, Yu ZX, Marozsan A, Wang Y, Pickering MC. Ruseva MM, et al. Among authors: lasaro ma. J Am Soc Nephrol. 2016 Feb;27(2):405-16. doi: 10.1681/ASN.2014121195. Epub 2015 Jun 5. J Am Soc Nephrol. 2016. PMID: 26047789 Free PMC article.
Leveraging Rational Protein Engineering to Improve mRNA Therapeutics.
Farelli JD, Asrani KH, Isaacs C, deBear JS, Stahley MR, Shah A, Lasaro MA, Cheng CJ, Subramanian RR. Farelli JD, et al. Among authors: lasaro ma. Nucleic Acid Ther. 2018 Apr;28(2):74-85. doi: 10.1089/nat.2017.0697. Epub 2018 Feb 13. Nucleic Acid Ther. 2018. PMID: 29437538
Role of complement activation in obliterative bronchiolitis post-lung transplantation.
Suzuki H, Lasbury ME, Fan L, Vittal R, Mickler EA, Benson HL, Shilling R, Wu Q, Weber DJ, Wagner SR, Lasaro M, Devore D, Wang Y, Sandusky GE, Lipking K, Pandya P, Reynolds J, Love R, Wozniak T, Gu H, Brown KM, Wilkes DS. Suzuki H, et al. J Immunol. 2013 Oct 15;191(8):4431-9. doi: 10.4049/jimmunol.1202242. Epub 2013 Sep 16. J Immunol. 2013. PMID: 24043901 Free PMC article.
Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1.
Apgar JF, Tang JP, Singh P, Balasubramanian N, Burke J, Hodges MR, Lasaro MA, Lin L, Millard BL, Moore K, Jun LS, Sobolov S, Wilkins AK, Gao X. Apgar JF, et al. Among authors: lasaro ma. CPT Pharmacometrics Syst Pharmacol. 2018 Jun;7(6):404-412. doi: 10.1002/psp4.12301. Epub 2018 Apr 26. CPT Pharmacometrics Syst Pharmacol. 2018. PMID: 29637732 Free PMC article.
CORRIGENDUM: Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1.
Apgar JF, Tang JP, Singh P, Balasubramanian N, Burke JM, Hodges MR, Lasaro MA, Lin L, Millard BL, Moore K, Jun LS, Sobolov S, Wilkins AK, Gao X. Apgar JF, et al. Among authors: lasaro ma. CPT Pharmacometrics Syst Pharmacol. 2020 Mar;9(3):185. doi: 10.1002/psp4.12484. CPT Pharmacometrics Syst Pharmacol. 2020. PMID: 32187857 Free PMC article. No abstract available.
16 results